Novavax (NVAX) Tax Provisions (2010 - 2026)
Novavax's Tax Provisions was $1.71 million in Q2 2026, up 80.9% from $946,000 a year earlier and up 73.7% from the prior quarter.
Powered by 
Analysis
Novavax (NVAX) Tax Provisions (2010 - 2026) Analysis & Trends
On a trailing twelve-month basis, Novavax's Tax Provisions was $2.42 million through Jun 30, 2026, down 71.8% year-over-year; for FY2025, it came in at $1.87 million, down 82.9% from FY2024.
- Tax Provisions shows a four-year compound annual growth rate of -49.7% (FY2021 to FY2025).
- In earlier years, Tax Provisions was $10.88 million in FY2024 (+435.9%), $2.03 million in FY2023 (-52.7%), $4.29 million in FY2022 (-85.3%) and $29.22 million in FY2021.
- The Q2 2026 figure marks the highest quarterly Tax Provisions since Q4 2024.
- Compared with a year earlier, Tax Provisions was higher in two of the last six quarters, with growth averaging 34.2%.
- The best year-over-year quarter for Tax Provisions over five years was Q4 2024 (growth of 341.3%); the worst was Q4 2025 (a decline of 95.0%).
- Per Business Quant data, NVAX's Tax Provisions in the three quarters before Q2 2026 was $985,000 (Q1 2026), $376,000 (Q4 2025) and -$657,000 (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Taxes (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 638.12 Bn | 556.64 Bn | 17.26 Bn | 1.21 Bn |
| 2 | AbbVie | 462.60 Bn | 435.75 Bn | 12.70 Bn | 662.00 Mn |
| 3 | Merck | 358.70 Bn | 313.13 Bn | 12.21 Bn | 654.00 Mn |
| 4 | Novartis Ag | 272.16 Bn | 228.03 Bn | 11.24 Bn | -1.01 Bn |
| 5 | Astrazeneca | 250.36 Bn | 223.92 Bn | 12.86 Bn | -291.00 Mn |
| 6 | Amgen | 227.87 Bn | 183.27 Bn | 7.24 Bn | 393.00 Mn |
| 7 | Gilead Sciences | 184.97 Bn | 159.08 Bn | 6.22 Bn | 242.00 Mn |
| 8 | Pfizer | 162.61 Bn | 109.56 Bn | 10.94 Bn | -407.00 Mn |
| 9 | Vertex Pharmaceuticals | 132.45 Bn | 104.46 Bn | 2.84 Bn | 292.00 Mn |
| 10 | Novavax | 1.78 Bn | -1.23 Bn | 42.45 Mn | 1.71 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 1.71 Mn |
| Mar 31, 2026 | 985,000.00 |
| Dec 31, 2025 | 376,000.00 |
| Sep 30, 2025 | -657,000.00 |
| Jun 30, 2025 | 946,000.00 |
| Mar 31, 2025 | 1.20 Mn |
| Dec 31, 2024 | 7.45 Mn |
| Sep 30, 2024 | -1.03 Mn |
| Jun 30, 2024 | 2.21 Mn |
| Mar 31, 2024 | 2.26 Mn |
| Dec 31, 2023 | 1.69 Mn |
| Sep 30, 2023 | -697,000.00 |
| Jun 30, 2023 | -143,000.00 |
| Mar 31, 2023 | 1.18 Mn |
| Dec 31, 2022 | -2.26 Mn |
| Sep 30, 2022 | 2.47 Mn |
| Jun 30, 2022 | 1.42 Mn |
| Mar 31, 2022 | 2.66 Mn |
| Dec 31, 2021 | 16.61 Mn |
| Sep 30, 2021 | 6.04 Mn |
API Access
Novavax Tax Provisions API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=tax-provisions&ticker=NVAX&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "tax-provisions", "ticker": "NVAX", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=tax-provisions&ticker=NVAX&period=max&api_key=YOUR_API_KEY");
const data = await res.json();